Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 5/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18127436 | 0.94 | SIGMAR1 (0.43) | SIGMAR1ALDH1A1KMT2ACYP1A2CYP3A4 | |
| SCHEMBL23838470 | 0.86 | NPSR1 (0.34) | ALDH1A1KMT2ACYP1A2CYP3A4CYP2D6 | |
| SCHEMBL19474333 | 0.86 | NPSR1 (0.34) | ALDH1A1KMT2ACYP1A2CYP3A4CYP2D6 | |
| SCHEMBL18081492 | 0.84 | MAPT (0.36) | ALDH1A1KMT2A | |
| SCHEMBL19654949 | 0.83 | MAPT (0.32) | ALDH1A1KMT2ACYP1A2CYP3A4CYP2D6 | |
| SCHEMBL15134163 | 0.82 | SIGMAR1 (0.35) | SIGMAR1 | |
| SCHEMBL21004214 | 0.81 | SIGMAR1 (0.43) | SIGMAR1ALDH1A1KMT2ACYP1A2CYP3A4 | |
| SCHEMBL19544819 | 0.80 | CYP2C9 (0.39) | SIGMAR1ALDH1A1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL18857097 | 0.80 | SIGMAR1 (0.47) | SIGMAR1ALDH1A1KMT2ACYP1A2CYP3A4 | |
| SCHEMBL23951442 | 0.78 | CASP3 (0.33) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11094888-B2 | Organic electroluminescent device using aryl amine derivative containing heterocycle | IDEMITSU KOSAN CO., LTD. (JP) | 2021-08-17 | — | — | US | disclosed |
| US-20180040828-A1 | ORGANIC ELECTROLUMINESCENT DEVICE USING ARYL AMINE DERIVATIVE CONTAINING HETEROCYCLE | IDEMITSU KOSAN CO., LTD. (JP) | 2018-02-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11094888-B2 | Organic electroluminescent device using aryl amine derivative containing heterocycle | SLC18A1, SLC18A2, AOC2 | SIGMAR1 871/4885ALDH1A1 171/4885KMT2A 2384/4885 |
| US-20180040828-A1 | ORGANIC ELECTROLUMINESCENT DEVICE USING ARYL AMINE DERIVATIVE CONTAINING HETEROCYCLE | SLC18A1, SLC18A2, AOC2 | SIGMAR1 871/4885ALDH1A1 171/4885KMT2A 2384/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.